I have cheap needles and only use one a day with no issues.
I use one needle for anout 5 -7 days with the bd fine ones and multiple injections each day. Only because I'm lazy... Not actually to save costs to NHS.
When I went back to MDI from
Pump (went on it 2010) I got out my needles for my pen that I used up until 2010. The needles were out of date in 2009 and only a few had gone from the box.
Not good practice I know!!
Hi Conrad, I've done that already with the pump that why I think I won't qualify for funding for cgm because the cgm is already proof I'm in control of it. (Mostly!!!!!)Ask your DSN about the circadian profile.
I used to use the Vibe, but changed to the Accu Chek Insight this year - the circadian profile algorithms have eradicated night time hypos and dawn phenomenon for me... you should be able to set 24 hourly basal rates on the Vibe if I recall correctly. (You will need to see your DSN to calculate the profile.)
OMG yes!When you couldn't get pen needles on prescription, you made them last longer... Once in the habit...
I know the NICE statement says something along the lines of the benefits of using CGM's are not proven. However, it's the apparent prohibitive cost of CGM's which makes it unlikely at the moment and the foreseeable future for the NHS to prescribe to all T1's. I know someone on here produced a cost comparison of all CGM's based on 2 years use. From memory I think it averaged about £1250 a year.
With these new NICE guidelines on testing stating T1's can test up to 10 times a day i.e. up to 300 strips a month or 6 x 50 packs). Well with say an average price per packet of 50 strips of £15 then yearly cost in strips alone is over £1k never mind the lancets. I realise some strips can be had for less but also for a lot more, not everyone will test 10 times a day and people with CGM's also use some strips but at the end of the day it's not a huge difference in cost. (If the strips used are £20 for 50 then the cost per year based on the above scenario is heading towards £1.5k). If the cost of CGM's reduced in price then it makes it even more of an attractive option.
Well call me skeptical (do I look skeptical?) but people have been investigating light based non invasive reading of BG for about 20 years and no one has produced a usable product yet. They always found there was too much variability in the signal to get any kind of consistency in the BG measurement. Prof Grant does not appear to have published his clinical pilot data anywhere I can find. His funding from BHF ran out in April so I guess that's why he published results in July... you can see that there might be a vested interest by some parties in bigging up the results. The description given in the Leeds Uni press release, quoted by all other sources I can find, doesn't even make any sense. Decay time of infrared laser induced flourescence in the glass film varies in relation to BG, just because the glass is in contact with the skin? I am not saying the device doesn't work on sound physical principles, just that Leeds Uni and the media in general have failed to coherently report what those physical principles are. Eg it would make a little more sense if it was the backscatter from a laser penetrating into the capillaries that was causing the film to flouresce.CGM/s may well be for every one as there's a non-invasive test coming in the near future which should be a one off cosr with no consumables and there's a few other in the pipeline atm
http://www.leeds.ac.uk/news/article...aily_finger_pricking_for_people_with_diabetes
The website of the company developing the product has the same unhelpful description of 'how it works' that was cut and pasted into the press release. It's unhelpful FAQ saysCGM/s may well be for every one as there's a non-invasive test coming in the near future which should be a one off cosr with no consumables and there's a few other in the pipeline atm
http://www.leeds.ac.uk/news/article...aily_finger_pricking_for_people_with_diabetes
Technical enquiries
Technical details and data will be presented and published in peer reviewed scientific literature as and when appropriate. GlucoSense Diagnostics Ltd is not able to respond to individual requests for further technical information.
The results of a pilot clinical study, carried out at the Leeds Institute of Cardiovascular and Metabolic Medicine suggests that the device will perform as well as conventional technologies.
That is almost certainly a below cost price. It's probably the cost of delivery and administration alone. Dexcom have a vested interest in providing them to researchers.Given the cost of sensors from Dexcom to researchers is around £33, someone is making a decent profit somewhere...
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?